The iQ Group Global

We find, fund and develop bioscience discoveries to create life-changing medical innovations.

What Starts Here Changes The World

[OncoTEX Inc. @OncoTex]

OncoTEX is proud to celebrate the 65th birthday of pioneer chemist and cancer survivor, Professor Jonathan Sessler. Prof Sessler’s Texaphyrin molecules are the prime components of our TEX Core anticancer drug platform, and will someday help save lives. https://t.co/kRRcxqIy2E

[Wyss Institute @wyssinstitute]

The Wyss Institute’s eRapid technology was licensed to Antisoma Therapeutics to fast-forward point-of-care diagnostics for infectious, immune, and cancer diseases, including COVID-19. #Diagnostics
https://t.co/dDxyPyGINv

[The iQ Group Global @TheiQGroup]

Our medtech member company Antisoma Therapeutics has secured a worldwide license for @wyssinstitute's eRapid multiplexed biosensor tech to create a point-of-care diagnostics test platform for COVID-19 & multiple disease biomarkers. #diagnostics #rapidtest https://t.co/QP3lNH1Rkl

[The iQ Group Global @TheiQGroup]

The iQ Group Global is proud to support #worldcancerday by helping #closethecaregap and create a future without cancer.

[The iQ Group Global @TheiQGroup]

.@OncoTex Inc.'s peer-reviewed @ChemSocRev submission highlights how the human immune system can be recruited to fight cancer cells using gold-based compounds.

[OncoTEX Inc. @OncoTex]

OncoTEX Inc. is pleased to announce its @ChemSocRev submission discussing how novel gold compounds can activate the immune system to destroy cancer. https://t.co/fbHkWhJqCu

[The iQ Group Global @TheiQGroup]

Painless glucose monitoring for people living with diabetes. LSBD, a subsidiary of The iQ Group Global, has filed an application with the FDA for Breakthrough Devices Designation for its Saliva Glucose Biosensor.

https://t.co/aQTOHoFNnJ

[The iQ Group Global @TheiQGroup]

U.S. oncology company @OncoTex, a subsidiary of The iQ Group Global, has acquired a novel gold compound technology, AuraTEX, that uses the body's immune system to help destroy cancer cells.
https://t.co/7Gu18NLP94

[The iQ Group Global @TheiQGroup]

The Biosensor Platform can measure glucose in saliva and is being designed to make painful blood finger-prick testing obsolete. https://t.co/V8Cy9ckyyk

[The iQ Group Global @TheiQGroup]

@LifeSciAdvisors Benchtop Bios Podcast, featuring Dr. @stevenboyages, Interim @gbs_inc CEO & Chairman of the Board, who provides an inside look at the Saliva Glucose Biosensor technology.

Listen here: https://t.co/rg8ViZA9yz

[The iQ Group Global @TheiQGroup]

NEWS: We are pleased to announce the completion of a clinical validation study showcasing the success of LSBD's rapid SARS-CoV-2 Antibody test.

Click here to read the full announcement: https://t.co/Mx8cJpLCHy

[The iQ Group Global @TheiQGroup]

NEWS: OncoTEX Inc. is pleased to announce it has received licensing for a gold compound platform technology that induces the body’s immune system to destroy cancer cells.

Read the full announcement here: https://t.co/3HSK6G15TI

[The iQ Group Global @TheiQGroup]

NEWS: OncoTEX Inc. appoints Chief Executive Officer, Dr Jonathan Arambula.

Read the full announcement here: https://t.co/AMblR2NssA

[The iQ Group Global @TheiQGroup]

You might have noticed the purple ribbon in our logo this month in support of #GynecologicCancerAwarenessMonth.

September is the time to help bring awareness to all gynecologic cancers. Visit https://t.co/E8Ry23kCpR for more information. #GCAM

[The iQ Group Global @TheiQGroup]

Engineers at MIT and Harvard University have designed a small tabletop device that can detect SARS-CoV-2 from a saliva sample in an hour. In a new study, they showed that the diagnostic is just as accurate as the PCR tests now used.

Read more here: https://t.co/6ddqJQ3iEi

[The iQ Group Global @TheiQGroup]

@BusinessInsider feature article on The iQ Group Global:

Read the full article here: https://t.co/0bPuQ3wr5B

#innovation #biotechnology #medicalresearch

https://t.co/3iWWWwfXm8

[Intelligent Bio Solutions (NASDAQ: $INBS) @ibs_inc_]

NEWS: $GBS Inc. Engages L.E.K. Consulting Hong Kong Pty Limited to Identify Potential Sublicensees in China for its Saliva-Glucose Diabetes Test.

Read more here: https://t.co/kSPy8lWN0G

#Biotechnology #diabetes #innovation #biosensor

[Intelligent Bio Solutions (NASDAQ: $INBS) @ibs_inc_]

NEWS: @abcnews Radio interview by Fran Kelly with $GBS Inc.’s Scientific Board Member, Professor Paul Dastoor, from the @Uni_Newcastle. In the interview, Professor Dastoor discusses the mechanism behind the innovative technology:
https://t.co/ooPpWkYp5T

[Reuters @Reuters]

ICYMI: Australian scientists say they have developed the ‘holy grail’ of blood sugar testing for diabetics https://t.co/hjttyJD4CG

[The iQ Group Global @TheiQGroup]

This National Diabetes Week, we are unmasking the world’s largest epidemic, Diabetes, to raise awareness about the real impact diabetes-related stigmas have on all aspects of life for people living with this disease.

Read more: https://t.co/lSr62Q3KF4

#NDW2021 @DiabetesAus

[Intelligent Bio Solutions (NASDAQ: $INBS) @ibs_inc_]

Our Saliva Glucose Biosensor featured on Channel @9NewsAUS earlier this week after $GBS was awarded a $6.3 million grant to create a manufacturing facility that "will help push the project into commercial production."

@Uni_Newcastle
https://t.co/gVtbg8hob1